Microarray: An Approach for Current Drug Targets
Journal:
Current Drug Metabolism
Volume:
9
Page:
221-231
Author(s):
Virendra S. Gomase, Somnath Tagore and Karbhari V. Kale
Mast Cells and Inflammatory Heart Disease: Potential Drug Targets
Journal:
Cardiovascular & Hematological Disorders-Drug Targets
Volume:
8
Page:
80-90
Author(s):
DeLisa Fairweather and Sylvia Frisancho-Kiss
Malignant Mesothelioma Resistance to Apoptosis: Recent Discoveries and their Implication for Effective Therapeutic Strategies
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
631-641
Author(s):
M. R. Rippo, F. Villanova and A. Procopio
Therapeutic Potential of Group III Metabotropic Glutamate Receptors
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
671-684
Author(s):
Hilde Lavreysen and Frank M. Dautzenberg
Cancer-Associated Carbonic Anhydrases and Their Inhibition
Journal:
Current Pharmaceutical Design
Volume:
14
Page:
685-698
Author(s):
J. Pastorek, S. Pastorekova and M. Zatovicova
Transferrin and the Transferrin Receptor: Of Magic Bullets and Other Concerns
Journal:
Inflammation & Allergy - Drug Targets (Discontinued)
Volume:
7
Page:
41-52
Author(s):
Maria F. Macedo and Maria de Sousa
Genomic Signatures for Individualized Treatment of Malignant Tumors
Journal:
Current Drug Discovery Technologies
Volume:
5
Page:
9-14
Author(s):
Manfred Kunz
MicroRNAs-Based Therapeutic Strategy for Virally Induced Diseases
Journal:
Current Drug Discovery Technologies
Volume:
5
Page:
49-58
Author(s):
Decheng Yang, Alhousseynou Sall, Zhen Liu, Huifang M. Zhang, Ji Yuan, Travis Lim and Yue Su
The PI3K/Akt Pathway: Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
7-18
Author(s):
Craig W. Lindsley, Stanley F. Barnett, Mark E. Layton and Mark T. Bilodeau
AKT Signaling in Regulating Angiogenesis
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
19-26
Author(s):
Bing-Hua Jiang and Ling-Zhi Liu